Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
The present study evaluated the role of various neurotransmitter systems in mediating buspirone's blockade of the fear-potentiated startle effect, where acoustic startle amplitude is normally increase in the presence of a light previously paired with a shock. Large lesions of the dorsal and median raphe nuclei or IP injections of the serotonin antagonists cinanserin (10 mg/kg) or cyproheptadine (5 mg/kg) did not alter fear-potentiated startle, nor did these treatments prevent buspirone (5 or 10 mg/kg SC) from blocking fear-potentiated startle. The 5-HT 1A agonist 8-OH-DPAT (2.5-10.0) did not block fear-potentiated startle even at doses that produced a marked "5-HT syndrome". Another 5-HT 1A agonist, ipsapirone (10-20 mg/kg), blocked potentiated startle only at a very high dose (40 mg/kg). p-Chlorophenylalanine and p-chloroamphetamine did not alter fear-potentiated startle. Finally, pretreatment with the benzodiazepine receptor antagonist RO-15-1788 (1 mg/kg); the opiate antagonist naloxone (2 mg/kg) or the alpha 2-adrenergic antagonist yohimbine (5 mg/kg) did not reduce fear-potentiated startle, nor did they prevent buspirone from blocking fear-potentiated startle. Taken together, the data do not support the hypothesis that buspirone's anxiolytic effects are mediated by actions at 5-HT 1A receptors and more generally indicate that serotonergic neurons do not play an important role in fear-potentiated startle.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is in line with the clinical observation that specific phobias respond less well to treatments such as citalopram than other pathological anxiety states (Baldwin et al, 2005) and with preclinical evidence in rodents showing that the serotonergic system may not be critical for the expression of phasic fear-potentiated startle (Davis et al, 1988).”
From Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety (2010) · cites this paper as Davis et al, 1988
Citations
Cites
Pazos, A., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855 · cited 1×
“Binding studies have indicated that the hippocampus has high densities of 5-HT1A binding sites (Pazos and Palacios 1985).”
BackgroundReconciling the role of central serotonin neurons in human and animal behavior
Soubrié, P. (1986) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00022871 · Cited by 996
Tricklebank, M. D., Forler, C., & Fozard, J. R. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90714-3 · Cited by 675 · cited 1×
“Moreover, exploratory studies showed that pindolol (10 mg/kg), another 5-HT1 antagonist (Tricklebank et al. 1984), also did not prevent buspirone's anxiolytic effect.”
BackgroundAn animal behavior model for studying central serotonergic synapses
Jacobs, B. L. (1976) · Life Sciences · doi:10.1016/0024-3205(76)90303-9 · Cited by 556 · cited 2×
“1986) or only weakly effective (Hjorth and Carlsson 1982) at producing the °'5-HT syndrome" characteristic of 5-HT1A receptor activation (Jacobs 1976).”
BackgroundAfferent projections to the rat locus coeruleus as determined by a retrograde tracing technique
Cedarbaum, J. M., & Aghajanian, G. K. (1978) · Journal of Comparative Neurology · doi:10.1002/cne.901780102 · Cited by 549 · cited 1×
“Second, unlike clonidine, which depresses single unit firing of locus coeruleus neurons (Cedarbaum and Aghajanian 1978), buspirone actually increases locus coeruleus firing through a mechanism independent of ~2-adrenergic receptors (Sanghera and German 1983).”
BackgroundHitchcock, J., & Davis, M. (1986) · Behavioral Neuroscience · doi:10.1037/0735-7044.100.1.11 · Cited by 541
Self-citationThe neurobiology of the nucleus accumbens
Bailey, P. E. (1982) · Neuroscience · doi:10.1016/0306-4522(82)90145-2 · Cited by 451 · cited 1×
“As indicated in the Introduction, buspirone has been reported to bind to dopamine receptors (Stanton et al. 1981; Peroutka 1985).”
Selective interaction of novel anxiolytics with 5-hydroxytryptamine1A receptors
Peroutka, S. J. (1985) · Biological Psychiatry · doi:10.1016/0006-3223(85)90194-5 · Cited by 369 · cited 1×
“Buspirone produces an agonistlike reduction in serotonin turnover in various areas of the rodent brain (Hjorth and Carlsson 1982) and it binds with high affinity to 5-HT1 receptors (Glasser and Traber 1983), probably of the 5-HTIA subtype (Peroutka 1985).”
BackgroundPsychopharmacology: The Third Generation of Progress
ROGERS, K. L. (1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.9.1161 · Cited by 290
Pharmacology and neurochemistry of buspirone.
Riblet, L. A., Taylor, D. P., Eison, M. S., & Stanton, H. C. (1982) · PubMed · Cited by 287
Parachlorophenylalanine Reversal of Tranylcypromine Effects in Depressed Patients
Shopsin, B. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770070041003 · Cited by 265 · cited 1×
“On the other hand, PCPA has been reported to increase anxiety in depressed patients treated with tranylcypromine (Shopsin et al. 1976).”
BackgroundDavis, M. (1979) · Psychopharmacology · doi:10.1007/bf00426027 · Cited by 263
Self-citationDavis, M., Redmond, D. E., & Baraban, J. M. (1979) · Psychopharmacology · doi:10.1007/bf00433036 · Cited by 259 · cited 4×
“The doses and pretreatment times were chosen on the basis of previous studies (Davis 1979a, b; Davis et al. 1979).”
BackgroundMethodInfluentialSelf-citationVanderMaelen, C. P., Matheson, G. K., Wilderman, R. C., & Patterson, L. A. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90343-2 · Cited by 233 · cited 1×
“Buspirone depresses the firing rates of dorsal raphe neurons following intravenous (de Montigny et al. 1984; Vandermaelen et al. 1986) or iontophoretic (Vandermaelen et al. 1986) administration, consistent with a proposed action as a presynaptic 5-HT1A agonist.”
BackgroundSerotonergic mechanisms in the behavioral effects of buspirone and gepirone
Eison, A. S., Eison, M. S., Stanley, M., & Riblet, L. A. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90577-0 · Cited by 197 · cited 2×
“On the other hand, buspirone has been reported to be ineffective (Eison et al. 1986) or only weakly effective (Hjorth and Carlsson 1982) at producing the °'5-HT syndrome" characteristic of 5-HT1A receptor activation (Jacobs 1976).”
BackgroundBiology of Serotonergic Transmission
VAUGHAN, P. F. T. (1983) · Biochemical Society Transactions · doi:10.1042/bst0110224a · Cited by 182
DEMONTIGNY, C. (1984) · Neuropharmacology · doi:10.1016/0028-3908(84)90095-9 · Cited by 170
Dopamine receptor antagonism by the novel antianxiety drug, buspirone
McMillen, B., Matthews, R., Sanghera, M., Shepard, P., & German, D. (1983) · The Journal of Neuroscience · doi:10.1523/jneurosci.03-04-00733.1983 · Cited by 158
The design and calibration of a startle measurement system
Cassella, J. V., & Davis, M. (1986) · Physiology & Behavior · doi:10.1016/0031-9384(86)90032-6 · Cited by 139 · cited 1×
“The appara tus used to measure startle has been described previously (Cassella and Davis 1986).”
MethodSelf-citationPich, E. M., & SAMANIN, R. (1986) · Psychopharmacology · doi:10.1007/bf00175204 · Cited by 139
Hjorth, S., & Carlsson, A. (1982) · European Journal of Pharmacology · doi:10.1016/0014-2999(82)90265-5 · Cited by 139 · cited 3×
“1986) or only weakly effective (Hjorth and Carlsson 1982) at producing the °'5-HT syndrome" characteristic of 5-HT1A receptor activation (Jacobs 1976).”
BackgroundBuspirone: Action on serotonin receptors in calf hippocampus
Gläser, T., & Traber, J. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90404-1 · Cited by 127 · cited 1×
“Buspirone produces an agonistlike reduction in serotonin turnover in various areas of the rodent brain (Hjorth and Carlsson 1982) and it binds with high affinity to 5-HT1 receptors (Glasser and Traber 1983), probably of the 5-HTIA subtype (Peroutka 1985).”
BackgroundDopamine and antianxiety activity
Taylor, D. P., Riblet, L. A., Stanton, H. C., Eison, A. S., Eison, M. S., & TEMPLE, D. L. J. (1982) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(82)90507-x · Cited by 114 · cited 1×
“One hypothesis is that buspirone's anxiolytic effect is attributable to an interaction with dopaminergic receptors (see Taylor et al. 1982, for review).”
BackgroundAnxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm
Kehne, J. H., Cassella, J. V., & Davis, M. (1988) · Psychopharmacology · doi:10.1007/bf00735872 · Cited by 93
Self-citationMorphine and naloxone: Effects on conditioned near as measured with the potentiated startle paradigm
Davis, M. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90063-3 · Cited by 85 · cited 1×
“…since previous research has shown that s t imulat ion of benzodiazepine, opiate, or e2-adrenergic receptors blocks fear-potent ia ted startle (Davis 1979a, b; Davis et al. 1979), specific antagonists for these receptors were tested for their abili ty to prevent buspirone 's b lockade of…”
BackgroundSelf-citationLack of central 5-hydroxytryptamine influence on the anticonflict activity of diazepam
Kilts, C. D., Commissaris, R. L., Cordon, J. J., & Rech, R. H. (1982) · Psychopharmacology · doi:10.1007/bf00432255 · Cited by 75 · cited 1×
“Thus, a large number of studies have shown that treatments that deplete 5-HT are associated with anticonflict effects (cf Soubrie 1986) although notable exceptions can be found (Commissaris and Rech 1982; Kilts et al. 1982).”
BackgroundDiazepam blocks fear-enhanced startle elicited electrically from the brainstem
Berg, W. K., & Davis, M. (1984) · Physiology & Behavior · doi:10.1016/0031-9384(84)90148-3 · Cited by 72 · cited 1×
“1979), by the opiate agonist morphine (Davis 1979b), or by the benzodiazepines diazepam or flurazepam (Davis 1979a; Berg and Davis 1984).”
BackgroundSelf-citationComparative neuropharmacology of buspirone and MJ-13805, a potential anti-anxiety drug
McMillen, B. A., & Mattiace, L. A. (1983) · Journal of Neural Transmission · doi:10.1007/bf01248997 · Cited by 72 · cited 1×
“Buspirone acts like a dopamine antagonist in that it markedly increases dopamine turnover (Hjorth and Carlson 1982; McMillen and McDonald 1983; McMillen and Mattiace 1983) and antagonizes apomorphine-induced stereotypies (Riblet et al.”
BackgroundBuspirone as a midbrain modulator: Anxiolysis unrelated to traditional benzodiazepine mechanisms
Eison, M. S., & Eison, A. S. (1984) · Drug Development Research · doi:10.1002/ddr.430040112 · Cited by 68
Buspirone: chemical profile of a new class of anxioselective agents.
Temple, D., Yevich, J. P., & New, J. S. (1982) · PubMed · Cited by 67
The effects of benzodiazepine and non-benzodiazepine anxiolytics on locus coeruleus unit activity
Sanghera, M. K., & German, D. C. (1983) · Journal of Neural Transmission · doi:10.1007/bf01248998 · Cited by 63 · cited 1×
“Second, unlike clonidine, which depresses single unit firing of locus coeruleus neurons (Cedarbaum and Aghajanian 1978), buspirone actually increases locus coeruleus firing through a mechanism independent of ~2-adrenergic receptors (Sanghera and German 1983).”
BackgroundÖgren, S. O. (1982) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(82)90040-5 · Cited by 59
Commissaris, R. L., & Rech, R. H. (1982) · Psychopharmacology · doi:10.1007/bf00432562 · Cited by 56 · cited 1×
“Thus, a large number of studies have shown that treatments that deplete 5-HT are associated with anticonflict effects (cf Soubrie 1986) although notable exceptions can be found (Commissaris and Rech 1982; Kilts et al. 1982).”
BackgroundÖgren, S. O. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90138-8 · Cited by 51
McMillen, B. A., & McDonald, C. C. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90240-x · Cited by 50 · cited 1×
“Buspirone acts like a dopamine antagonist in that it markedly increases dopamine turnover (Hjorth and Carlson 1982; McMillen and McDonald 1983; McMillen and Mattiace 1983) and antagonizes apomorphine-induced stereotypies (Riblet et al.”
BackgroundInteraction of buspirone and dopaminergic agents on punished behavior of pigeons
Witkin, J. M., & Barrett, J. E. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90585-x · Cited by 49
Serotonin and fear retention in the rat.
Archer, T. (1982) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0077897 · Cited by 42
Ögren, S. O., & Johansson, C. (1985) · Psychopharmacology · doi:10.1007/bf00431678 · Cited by 42
Mianserin in the treatment of depressive illness and anxiety states in general practice.
Murphy, J. E. (1978) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1978.tb04581.x · Cited by 39
Monoaminergic involvement in the pharmacological actions of buspirone
Skolnick, P., Weissman, B. A., & Youdim, M. B. H. (1985) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1985.tb08940.x · Cited by 39 · cited 1×
“In fact, buspirone has sometimes been reported to act like a 5-HT antagonist, since it can attenuate the "5-HT syndrome" produced by 5-methoxyN,N-dimethyltryptamine (Skolnick et al. 1985; Lucki and Ward 1986) or by 8-OH-DPAT (Reynolds et al. 1986).”
BackgroundA pilot study of the effect of the 5‐HT‐uptake inhibitor, zimelidine, on phobic anxiety
Koczkas, S., Holmberg, G., & Wedin, L. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb00736.x · Cited by 31 · cited 1×
“Anxiolytic properties have been reported for the serotonin antagonist mianserin (Murphy 1978) and for the serotonin uptake blocker zimelidine (Evans and Moore 1981; Koczkas et al. 1981).”
BackgroundThe treatment of phobic anxiety by zimelidine
Evans, L., & Moore, G. E. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb00737.x · Cited by 23 · cited 1×
“Anxiolytic properties have been reported for the serotonin antagonist mianserin (Murphy 1978) and for the serotonin uptake blocker zimelidine (Evans and Moore 1981; Koczkas et al. 1981).”
BackgroundLouilot, A., Moal, M. L., & Simon, H. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90015-9 · Cited by 17
Mauk, M. D., Peroutka, P. J., & Kocsis, J. D. (1985) · The Society for Neuroscience Abstracts · Cited by 3
Research works printed but not linked: 4
- Andrade R, Nicoll RA (1985) The novel anxiolytic buspirone elicits a small hyperpolarization and seduces serotonin responses at putative 5-HT1 receptors on hippocampal CA1 pyramidal cells. Soc Neurosci Abstr 11:597
- Lucki I, Ward HR (1986) Antagonism of serotonin-mediated behaviors in rats by pretreatment with the non-benzodiazepine anxiolytics buspirone or ipsapirone. Soc Neurosci Abstr 12:1236
- Mauk MD, Peroutka SJ, Kocsis JD (1985) Modulation of synaptic transmission in the hippocampus produced by novel anxiolytics (Buspirone, TVX-Q & DPAT). Soc Neurosci Abstr 11:135
- Reynolds LS, Seymour PA, Heym J (1986) Inhibition of the behavioral effects of 8-OH-DPAT by the novel anxiolytics buspirone, gepirone and isapirone. Soc Neurosci Abstr 12:481
Cited by
Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety
Davis, M., Walker, D. L., Miles, L., & Grillon, C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.109 · Cited by 1,513
Self-citationFear-potentiated startle: A neural and pharmacological analysis
Davis, M., Falls, W. A., Campeau, S., & Kim, M. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90102-v · Cited by 748
Self-citationGriebel, G. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)98597-j · Cited by 488
DAVIS, M., WALKER, D. L., & LEE, Y. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48289.x · Cited by 281
Self-citationAggression, anxiety and vocalizations in animals: GABAA and 5-HT anxiolytics
Miczek, K. A., Weerts, E. M., Vivian, J. A., & Barros, H. M. (1995) · Psychopharmacology · doi:10.1007/bf02245590 · Cited by 275
Metadata
- Authors
- Davis, M., Cassella, J. V., & Kehne, J. H.
- Affiliations
- Yale University (US)
- ORCID
- Cassella, J. V.
- Venue
- Psychopharmacology
- Published
- 1988
- Volume
- 94
- Issue
- 1
- Pages
- 14-20
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2015340606
- Cited by
- 94
- References
- 44
- Citations by year
- 2023: 1 · 2018: 1 · 2016: 2 · 2015: 1 · 2013: 1 · 2012: 1
- FWCI
- 3.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH 25642, MH 00004)
- National Institute of Neurological Disorders and Stroke (NS-18033)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Keywords
- buspirone, serotonin, 5-HT1A receptor, fear-potentiated startle, anxiolytic effects, dorsal raphe nucleus, median raphe nucleus, cinanserin, cyproheptadine, 8-OH-DPAT, ipsapirone, benzodiazepine receptor, naloxone, yohimbine, p-chlorophenylalanine, p-chloroamphetamine, acoustic startle response
- MeSH terms
- Acoustic Stimulation, Animals, Buspirone, Conditioning, Operant, Fear, Male, Fenclonine, Pyrimidines, Raphe Nuclei, Rats, Inbred Strains, Serotonin, Serotonin Antagonists, Reflex, Startle, Tetrahydronaphthalenes, Anti-Anxiety Agents, 8-Hydroxy-2-(di-n-propylamino)tetralin, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.